moxifloxacin has been researched along with Liver Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abousoud, O; Dagli, M; Gade, T; Hunt, S; Mondschein, J; Nadolski, GJ; Parikh, RS; Shamimi-Noori, S; Soulen, MC; Stavropoulos, SW; Sudheendra, D | 1 |
Guo, Y; Hu, Y; Huang, Y; Liu, D; Lu, B; Wang, X; Zhu, Z | 1 |
Brown, DB; Eschelman, DJ; Gonsalves, CF; Khan, W; McCann, JW; Sato, T; Sullivan, KL | 1 |
Hirschmann, K; Justinger, C; Kauffels, A; Kees, F; Kees, MG; Kollmar, O; Kopp, B; Schilling, MK | 1 |
1 trial(s) available for moxifloxacin and Liver Neoplasms
Article | Year |
---|---|
Penetration of moxifloxacin into liver tissue.
Topics: Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Female; Fluoroquinolones; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Moxifloxacin; Quinolines; Treatment Outcome; Young Adult | 2012 |
3 other study(ies) available for moxifloxacin and Liver Neoplasms
Article | Year |
---|---|
Infection Rates Following Hepatic Embolotherapy in Patients with Prior Biliary Interventions: Comparison of Single-Drug Moxifloxacin and Multidrug Antibiotic Prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biliary Tract Surgical Procedures; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Drug Therapy, Combination; Female; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Moxifloxacin; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.
Topics: Adaptor Proteins, Signal Transducing; Annexin A2; Anti-Bacterial Agents; Antineoplastic Agents; Azithromycin; Carcinoma, Hepatocellular; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoroquinolones; Gemcitabine; Humans; Liver Neoplasms; Mitoxantrone; Moxifloxacin; Mycoplasma hyorhinis; Protein Binding; Real-Time Polymerase Chain Reaction | 2017 |
Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Biliary Tract Diseases; Case-Control Studies; Chemoembolization, Therapeutic; Embolization, Therapeutic; Ethiodized Oil; Female; Fluoroquinolones; Humans; Liver Abscess; Liver Neoplasms; Male; Moxifloxacin; Pilot Projects; Quinolines; Radiography, Interventional; Retrospective Studies; Risk Factors | 2011 |